OpenResearchAlpha

Philosophical Transactions of the Royal Society B: Biological Sciences · 12 Nov 2026

Reactivating young muscle regenerative pathways in ageing through inhibition of the ‘gerozyme’ 15-hydroxyprostaglandin dehydrogenase

Minas Nalbandianh-index 8, Helen M. Blauh-index 14

0
Citations
no database records one yet
0
Citations in 2026
so far
14
Leading author's h-index
Helen M. Blau, in QAI's scholar index
97
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract We are living longer, but the years lived free from chronic diseases and disabilities have not increased at the same rate. The loss of skeletal muscle function in late life constitutes a major barrier to achieving this goal. With age, muscle mass and strength progressively decline. When the loss of muscle function becomes pathological, it is clinically recognized as a syndrome, sarcopenia. The goal of our laboratory is to understand the cellular and molecular mechanisms that drive muscle ageing and sarcopenia and to identify therapeutic strategies that preserve or restore muscle function in older individuals. In this review, we discuss our discovery of the gerozyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH), a molecular driver of ageing that impedes muscle tissue growth, maintenance and regeneration. 15-PGDH abundance and enzymatic activity increase with age, leading to degradation of prostaglandin E2 (PGE2), a lipid mediator with key roles in skeletal muscle regeneration and tissue homeostasis. By limiting PGE2 bioavailability, elevated 15-PGDH contributes to the impaired regenerative and adaptive capacity of aged muscle. Pharmacological inhibition of 15-PGDH restores PGE2 signalling and improves muscle mass, strength and regenerative capacity in old mice and constitutes a promising therapeutic strategy to counter sarcopenia and promote late-life muscle function. This article is part of the theme issue ‘Developmental circuits in ageing’.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Helen M. Blau has the highest h-index among the authors (14).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (2)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (97)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 77 more references

A free account opens the rest of the citing papers and references on every paper’s page.